Screener
Corcept Therapeutics CORT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's net margin?
- Corcept Therapeutics (CORT) reported net margin of 6.6% in Q2 2026.
- How has Corcept Therapeutics's net margin changed year-over-year?
- Corcept Therapeutics's net margin decreased by 64.4% year-over-year, from 18.7% to 6.6%.
- What is the long-term trend for Corcept Therapeutics's net margin?
- Over 5 years (2020 to 2025), Corcept Therapeutics's net margin has grown at a -15.3% compound annual growth rate (CAGR), from 30% to 13.1%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Corcept Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude